In March 2017 we wrote this article, “Breast Implants Linked to Rare Lymphoma Blood Cancer“, which started our coverage of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) related to textured breast implants. Seven years later, we point out an article published on February 27, 2024, by the Plastic and Reconstructive Surgery medical journal that serves to present what can be fairly described as a 2024 BIA-ALCL report by the American Association of Plastic Surgeons.
This 2024 BIA-ALCL report describes evidence regarding the risk, diagnosis, and management of the anaplastic large cell lymphoma that has been linked to textured breast implants. It emphasizes that the possible prophylactic explantation (removal) of textured breast implants as a potential BIA-ALCL risk reduction measure should be the subject of an informed discussion between a woman and her surgeon.
From the Abstract for this February 2024 medical journal article, “Breast Implant Associated Anaplastic Large Cell Lymphoma: Evidence-Based Consensus Conference Statement From The American Association of Plastic Surgeons“, we get the following excerpts:
- “In the absence of high-quality evidence, there is a need to provide guidelines and multidisciplinary consensus recommendations on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).”
- “The analysis encompassed a comprehensive examination of the selected articles to determine the incidence, risk factors, clinical presentation, diagnostic approaches, and treatment modalities related to BIA-ALCL.”
- “Plastic surgeons should be aware of the elevated risks by surface type, implement appropriate patient surveillance, and follow the recommendations outlined in this statement to ensure patient safety and optimize outcomes.”
We have been monitoring the medical literature for updates on BIA-ALCL and textured breast implants over the past seven years, and that is how we found this 2024 BIA-ALCL report by the American Association of Plastic Surgeons. Over time, we have reported significant developments in past articles, which have been listed on our Breast Implants Cases Overview page.
We continue to handle cases of breast implant-associated lymphoma, and we offer a Free Case Evaluation for women diagnosed with BIA-ALCL.